Cancer Immunotherapy by Delivering Class II MHC Antigens Using a VLP-Replicon
Technology
E-050-2014
Patent ID
E-050-2014-0-CN-21
Country
CN
Application Type
DIV
Patent Status
Abandoned
Patent Number
Publication Number
CN113648406A
Application Number
202110829496.3
IC
NCI
Date Filed
Date Issued
Patent PDF